2019
Analysis of Temporal Trends and Variation in the Use of Defibrillation Testing in Contemporary Practice
Borne RT, Randolph T, Wang Y, Curtis JP, Peterson PN, Masoudi FA, Sandhu A, Zipse MM, Thomas K, Kutyifa V, Desai NR, Cha YM, Hsu JC, Russo AM. Analysis of Temporal Trends and Variation in the Use of Defibrillation Testing in Contemporary Practice. JAMA Network Open 2019, 2: e1913553. PMID: 31626314, PMCID: PMC6813586, DOI: 10.1001/jamanetworkopen.2019.13553.Peer-Reviewed Original ResearchConceptsNational Cardiovascular Data Registry ICD RegistryMedian odds ratioDefibrillation testingLow testing ratesTesting ratesHigher testing ratesICD RegistryFirst-time ICD implantationImplantable cardioverter defibrillator implantationMulticenter cross-sectional studyAdvanced heart failureCardioverter-defibrillator implantationIschemic heart diseaseCross-sectional studyICD implantationHeart failureICD placementVentricular arrhythmiasMean ageHeart diseaseVentricular tachycardiaOdds ratioHigher oddsMAIN OUTCOMEFirst calendar quarterInstitutional Variation in Quality of Cardiovascular Implantable Electronic Device Implantation: A Cohort Study.
Ranasinghe I, Labrosciano C, Horton D, Ganesan A, Curtis JP, Krumholz HM, McGavigan A, Hossain S, Air T, Hariharaputhiran S. Institutional Variation in Quality of Cardiovascular Implantable Electronic Device Implantation: A Cohort Study. Annals Of Internal Medicine 2019, 171: 309-317. PMID: 31357210, DOI: 10.7326/m18-2810.Peer-Reviewed Original ResearchConceptsCardiovascular implantable electronic devicesComplication rateCohort studyCIED complicationsCardiovascular implantable electronic device (CIED) implantationMajor device-related complicationsDays of dischargeDevice-related complicationsProcedure-related complicationsImplantable electronic devicesPPM implantationMajor complicationsICD placementDevice implantationElective proceduresComplicationsHospitalCare qualityStudy periodPatientsAdministrative dataInstitutional variationNational averageImplantation
2017
Use of Cardiac Resynchronization Therapy Among Eligible Patients Receiving an Implantable Cardioverter Defibrillator: Insights From the National Cardiovascular Data Registry Implantable Cardioverter Defibrillator Registry
Marzec LN, Peterson PN, Bao H, Curtis JP, Masoudi FA, Varosy PD, Bradley SM. Use of Cardiac Resynchronization Therapy Among Eligible Patients Receiving an Implantable Cardioverter Defibrillator: Insights From the National Cardiovascular Data Registry Implantable Cardioverter Defibrillator Registry. JAMA Cardiology 2017, 2: 561-565. PMID: 28122073, PMCID: PMC5814986, DOI: 10.1001/jamacardio.2016.5388.Peer-Reviewed Original ResearchMeSH KeywordsAgedAged, 80 and overAtrial FibrillationBlack or African AmericanBundle-Branch BlockCardiac Resynchronization TherapyCardiac Resynchronization Therapy DevicesCerebrovascular DisordersCohort StudiesComorbidityDefibrillators, ImplantableDiabetes MellitusEthnicityFemaleHealth Facility SizeHeart FailureHospitalsHospitals, TeachingHumansHypertensionInsurance, HealthLung DiseasesMaleMedicaidMedicareMiddle AgedMortalityMyocardial IschemiaPractice Patterns, Physicians'RegistriesRegression AnalysisRetrospective StudiesUnited StatesWhite PeopleConceptsUse of CRTCardiac resynchronization therapyCRT-D useImplantable cardioverter defibrillatorGuideline-eligible patientsDevice implantationEligible patientsResynchronization therapyCardioverter defibrillatorNational Cardiovascular Data Registry Implantable Cardioverter Defibrillator RegistryNational Cardiovascular Data Registry ICD RegistryHeart failure-related eventsImplantable Cardioverter-Defibrillator RegistryCRT-D groupMulticenter retrospective cohortRisk-standardized ratesHospital-level variationCRT-D devicesHierarchical multivariable modelNonprivate insuranceRetrospective cohortSelect patientsICD RegistryGuideline recommendationsICD placement
2015
A validated risk model for 1-year mortality after primary prevention implantable cardioverter defibrillator placement
Heidenreich PA, Tsai V, Curtis J, Wang Y, Turakhia MP, Masoudi FA, Varosy PD, Goldstein MK. A validated risk model for 1-year mortality after primary prevention implantable cardioverter defibrillator placement. American Heart Journal 2015, 170: 281-289.e2. PMID: 26299225, DOI: 10.1016/j.ahj.2014.12.013.Peer-Reviewed Original ResearchConceptsOne-year mortalityImplantable cardioverter defibrillatorRisk factorsHeart failurePrimary preventionMortality riskRisk scorePrimary prevention implantable cardioverter-defibrillator placementB-type natriuretic peptide valuesImplantable cardioverter-defibrillator placementCardiovascular Disease RegistryPrimary prevention populationNatriuretic peptide valuesChronic lung diseaseSystolic blood pressureSimilar risk factorsBlood urea nitrogenPg/mLLogistic regression modelsPrevention populationICD therapyICD implantationBlood pressureICD RegistryICD placement
2014
Survival After Primary Prevention Implantable Cardioverter-Defibrillator Placement Among Patients With Chronic Kidney Disease
Hess PL, Hellkamp AS, Peterson ED, Sanders GD, Al-Khalidi HR, Curtis LH, Hammill BG, Pun PH, Curtis JP, Anstrom KJ, Hammill SC, Al-Khatib SM. Survival After Primary Prevention Implantable Cardioverter-Defibrillator Placement Among Patients With Chronic Kidney Disease. Circulation Arrhythmia And Electrophysiology 2014, 7: 793-799. PMID: 25038119, PMCID: PMC4206571, DOI: 10.1161/circep.114.001455.Peer-Reviewed Original ResearchMeSH KeywordsAgedCause of DeathChi-Square DistributionComorbidityDeath, Sudden, CardiacDefibrillators, ImplantableElectric CountershockFemaleGlomerular Filtration RateHeart FailureHumansKaplan-Meier EstimateKidneyLinear ModelsMaleMiddle AgedMultivariate AnalysisPatient SelectionPrimary PreventionProportional Hazards ModelsProsthesis DesignRegistriesRenal Insufficiency, ChronicRisk AssessmentRisk FactorsSeverity of Illness IndexTime FactorsTreatment OutcomeUnited StatesConceptsChronic kidney diseasePrimary prevention ICD placementRisk of deathICD placementCKD severityKidney diseaseNational Cardiovascular Data Registry ICD RegistryPrimary prevention implantable cardioverter-defibrillator placementGlomerular filtration rate 30Implantable cardioverter-defibrillator candidatesEnd-stage renal diseaseImplantable cardioverter-defibrillator placementSocial Security Death Master FileHeart failure symptomsLow ejection fractionGlomerular filtration rateRate of deathDeath Master FileICD candidacyCKD stageDiabetes mellitusEjection fractionICD RegistryRenal diseaseSerum sodium
2013
Developing a Risk Model for In-Hospital Adverse Events Following Implantable Cardioverter-Defibrillator Implantation A Report From the NCDR (National Cardiovascular Data Registry)
Dodson JA, Reynolds MR, Bao H, Al-Khatib SM, Peterson ED, Kremers MS, Mirro MJ, Curtis JP, NCDR. Developing a Risk Model for In-Hospital Adverse Events Following Implantable Cardioverter-Defibrillator Implantation A Report From the NCDR (National Cardiovascular Data Registry). Journal Of The American College Of Cardiology 2013, 63: 788-796. PMID: 24333491, PMCID: PMC3954985, DOI: 10.1016/j.jacc.2013.09.079.Peer-Reviewed Original ResearchConceptsHospital adverse eventsAdverse eventsComplication rateValidation cohortRisk scoreIn-Hospital Adverse EventsImplantable cardioverter defibrillator implantationICD implantation procedureOutcomes of patientsCardioverter-defibrillator implantationHigh-risk subgroupsMultivariable logistic regressionHospital complicationsPeriprocedural complicationsICD implantationICD placementAdverse outcomesRisk subgroupsProcedural volumeStudy groupPatientsProlong lifeCase mixA ReportImplantation procedurePrevalence, Correlates, and Temporal Trends in Antiarrhythmic Drug Use at Discharge After Implantable Cardioverter Defibrillator Placement (from the National Cardiovascular Data Registry [NCDR])
Dev S, Peterson PN, Wang Y, Curtis JP, Varosy PD, Masoudi FA. Prevalence, Correlates, and Temporal Trends in Antiarrhythmic Drug Use at Discharge After Implantable Cardioverter Defibrillator Placement (from the National Cardiovascular Data Registry [NCDR]). The American Journal Of Cardiology 2013, 113: 314-320. PMID: 24216126, DOI: 10.1016/j.amjcard.2013.09.023.Peer-Reviewed Original ResearchConceptsImplantable cardioverter defibrillatorAntiarrhythmic drug useAntiarrhythmic drugsMedian odds ratioHospital dischargeOdds ratioSecondary prevention implantable cardioverter defibrillatorDrug useClass III antiarrhythmic drugsImplantable cardioverter-defibrillator placementMultivariate logistic regression modelHospital-level variationClass III agentsLocal treatment patternsLogistic regression modelsFacility-level variablesAntiarrhythmic useICD implantationICD recipientsICD RegistryHospital variationICD placementTreatment patternsDevice shocksAntiarrhythmic agents
2010
Regional Variation in the Use of Implantable Cardioverter-Defibrillators for Primary Prevention
Matlock DD, Peterson PN, Heidenreich PA, Lucas FL, Malenka DJ, Wang Y, Curtis JP, Kutner JS, Fisher ES, Masoudi FA. Regional Variation in the Use of Implantable Cardioverter-Defibrillators for Primary Prevention. Circulation Cardiovascular Quality And Outcomes 2010, 4: 114-121. PMID: 21139094, DOI: 10.1161/circoutcomes.110.958264.Peer-Reviewed Original ResearchConceptsPrimary prevention ICDsProportion of patientsTrial inclusion criteriaInclusion criteriaPrimary preventionTrial criteriaPhysician supplyNational Cardiovascular Data RegistryImplantable cardioverter defibrillatorHospital referral regionsRace-adjusted ratesCross-sectional analysisICD implantationICD placementCardioverter defibrillatorReferral regionsData registryPotential overusePatientsICDDeath variesRate ratioService populationGeographic variationRegional variation
2009
Use of implantable cardioverter defibrillators for primary prevention in the community: Do women and men equally meet trial enrollment criteria?
Daugherty SL, Peterson PN, Wang Y, Curtis JP, Heidenreich PA, Lindenfeld J, Vidaillet HJ, Masoudi FA, behalf of the NCDR O. Use of implantable cardioverter defibrillators for primary prevention in the community: Do women and men equally meet trial enrollment criteria? American Heart Journal 2009, 158: 224-229. PMID: 19619698, DOI: 10.1016/j.ahj.2009.05.018.Peer-Reviewed Original ResearchConceptsTrial enrollment criteriaPrimary prevention ICD implantationEnrollment criteriaICD implantationMADIT-IIMultivariable analysisPrimary preventionTrial criteriaNational Cardiovascular Data Registry ICD RegistryPrimary prevention ICD placementImplantable cardioverter defibrillator implantationSCD-HeFT trialsCardioverter-defibrillator implantationSudden cardiac deathImplantable cardioverter defibrillatorDefibrillator implantationSCD-HeFTYounger patientsCardiac deathICD RegistryICD placementNational cohortCardioverter defibrillatorOlder womenPatients